case_images: PMC9174998_01
case_images: Case presentation of case 1. CCRT, concurrent radiotherapy; CR, complete remission; CT, computed tomography; N, lymphonodus; PR, partial remission; PD, progression disease; RT, radiotherapy; T, tumor; TC, paclitaxel/carboplatin.
case_images: fonc-12-794153-g001.jpg
case_images: PMC9174998_01_fonc-12-794153-g001.jpg
case_images: f1
case_images: To date, the patient is in a stable condition with no severe adverse reactions and an overall survival (OS) time that has exceeded 21 months (Figure 1).
case_images: The timeline of diagnosis, interventions, and outcomes of case 1. SCC, squamous cell carcinoma; EGJ, esophagogastric junction; CT, computed tomography; cCCR, concurrent chemoradiotherapy.
case_images: fonc-12-794153-g002.jpg
case_images: PMC9174998_01_fonc-12-794153-g002.jpg
case_images: f2
case_images: The timeline of diagnosis, interventions and outcomes was summarized as  Figure 2 .
case_images: PMC9174998_02
case_images: Case presentation of case 2. CCRT, concurrent radiotherapy; CR, complete remission; CT, computed tomography; PR, partial remission; SD, stable disease; T, tumor; TC, paclitaxel/carboplatin; TP, paclitaxel/cis-platinum.
case_images: fonc-12-794153-g003.jpg
case_images: PMC9174998_02_fonc-12-794153-g003.jpg
case_images: f3
case_images: To date, the patient's condition has remained stable; the quality of life is good with an absence of severe adverse reactions, and OS time has exceeded 21 months (Figure 3).
case_images: The timeline of diagnosis, interventions, and outcomes of case 2. SCC, squamous cell carcinoma; EGJ, esophagogastric junction; CT, computed tomography.
case_images: fonc-12-794153-g004.jpg
case_images: PMC9174998_02_fonc-12-794153-g004.jpg
case_images: f4
case_images: The timeline of diagnosis, interventions and outcomes was summarized as  Figure 4 .